Vineet Laboratories Share Price

Vineet Laborator Corporate Action

CMP as on 12-Aug-22 15:42

₹ 57.55
-0.40 -0.69%

Open

₹ 58.00

Turnover (lac)

₹ 4

Prev. Close

₹ 57.95

Day's Vol (shares)

₹ 6,419

Day's Range (₹)

₹ 57.00
₹ 59.00

CMP as on12-Aug-22 15:27

₹ 57.75
-0.2 -0.35%

Open

₹ 57.00

Turnover (lac)

Prev. Close

₹ 57.95

Day's Vol (shares)

₹ 2,532

Day's Range

₹ 56.65
₹ 58.20

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 21-Jul-2022 - -
Quarterly Results With reference to the above-mentioned subject, we hereby submit the revised Audited Financial Results of the company for the Fourth Quarter and the Financial Year ended on 31st March, 2022. More specifically, rectifying the figures (Total Comprehensive Income and EPS) for the quarter ended 31st March, 2022. The error was unintentional and due to oversight. Inconvenience regretted. (As Per BSE Announcement Dated on 23.07.2022) Considered and adopted unaudited Financials results for Quarter ended June 30,2022 along with Limited review Report (As per BSE Announcement Dated on 29/07/2022)
Board Meeting - 20-May-2022 - -
Audited Results Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 28, 2022 at 4:00pm. The purpose of the Board Meeting is - among other matters- 1. The Annual Audited Financial Results for the Fourth Quarter and Financial Year ended 31st March 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Other Corporate Matters. The Board of Directors in the meeting held on 28 May, 2022 has recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022. The Board of Directors of the company in its meeting held today i.e., on May 28, 2022 has considered and approved the following: 1. The Annual Audited Financial Results of the company for the Fourth Quarter and the Financial Year ended on 31st March, 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Independent Auditors Report on Quarterly Standalone Financial Results and Year to Date. 4. Recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022. The Board Meeting commenced at 04.00 PM and concluded at 08.00 PM (As Per BSE Announcement Dated on 28/05/2022)
Board Meeting - 04-Feb-2022 - -
Quarterly Results The Board of Directors of the company in its meeting held on February 12, 2022 has considered and approved the Un-audited Financial Results of the company for the Quarter and Nine months ended on 31st December, 2021; Limited Review Report issued by the Statutory Auditor (As Per BSE Announcement Dated on 12.02.2022)
Board Meeting - 01-Nov-2021 - -
Quarterly Results Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2021 ,inter alia, to consider and approve Un-Audited Financial Results of the Company For The Quarter And Half Year Ended 30th September, 2021. Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2021 (As Per BSE Announcement Dated on 10/11/2021)
Board Meeting - 31-Aug-2021 - -
Outcome of Board meeting held on 31.08.2021 With reference to the subject cited, this is to inform the Exchange that due to unavoidable circumstances the Annual General Meeting of the Company is postponed from 23.09.2021 to Thursday, 30.09.2021 at 2:00 p.m. through video conferencing/other audio visual means.
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity